AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (October 18, 2005). doi:10.1152/ajprenal.00301.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/F1163    most recent
00301.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, Y.
Right arrow Articles by Wang, W.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, Y.
Right arrow Articles by Wang, W.-H.
Submitted on July 27, 2005
Accepted on October 13, 2005

Adenosine inhibits epithelial Na channels (ENac) by cytochrome-P450 (CYP)-epoxygenase-dependent metabolites of arachidonic acid

Yuan Wei1, Peng Sun1, ZhiJian Wang1, BaoFeng Yang2, and Wen-Hui Wang1*

1 Department of Pharmacology, New York Medical College, Valhalla, NY, USA
2 Department of Pharmacology, Harbin Medical University, Harbin, China

* To whom correspondence should be addressed. E-mail: wenhui_wang{at}nymc.edu.

We used the patch-clamp technique to examine the effect of adenosine on ENaC activity in the rat cortical collecting duct (CCD). Application of cyclohexyladenosine (CHA), an A1 adenosine receptor agonist, inhibited the ENaC activity, defined by NPo, from 1.32 to 0.64. The inhibitory effect of CHA on ENaC was mimicked by cyclopentyladenosine (CPA) which reduced channel activity from 1.1 to 0.55. In contrast, application of CGS21680, an A2a adenosine receptor agonist, had no effect on ENaC and increased channel activity from 0.96 to 1.22. This suggests that the inhibitory effect of adenosine analogs resulted from the stimulation of the A1 adenosine receptor. Inhibition of phospholipase C with U73122 failed to abolish the effect of CHA on ENaC. In contrast, the inhibitory effect of CHA on ENaC was absent in the presence of the phospholipase A2 inhibitor , AACOCF3. This suggests a role of arachidonic acid (AA) in mediating the effect of adenosine on ENaC. To determine the metabolic pathway of AA responsible for the effect of adenosine, we examined the effect of CHA in the presence of indomethacin or MS-PPOH. Inhibition of CYP450 epoxygenase with MS-PPOH blocked the effect of CHA on ENaC. In contrast, CHA reduced the ENaC activity in the presence of indomethacin. This suggests that CYP-epoxygenase dependent metabolites of AA mediate the effect of adenosine. Since 11,12-epoxyeicosatrienoic acid (11,12-EET) inhibits ENaC activity in the CCD (26), the role of 11,12-EET in mediating the effect of adenosine on ENaC was examined. Addition of 11,12-EET inhibited the ENaC channels in the CCD in which adenosine-induced inhibition was blocked by AACOCF3. We conclude that adenosine inhibits ENaC activity by stimulation of the A1 adenosine receptor in the CCD and that the effect of adenosine is mediated by 11,12-EET.




This article has been cited by other articles:


Home page
HypertensionHome page
J. D. Imig
Adenosine2A Receptors and Epoxyeicosatrienoic Acids: A Recipe for Salt and Blood Pressure Regulation
Hypertension, December 1, 2009; 54(6): 1223 - 1225.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. L. Liclican, J. C. McGiff, J. R. Falck, and M. A. Carroll
Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats
Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1696 - F1704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Z. Wang, Y. Wei, J. R. Falck, K. R. Atcha, and W.-H. Wang
Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1441 - F1447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Li, C. S. Wingo, and S.-L. Xia
Downregulation of SGK1 by nucleotides in renal tubular epithelial cells
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1751 - F1757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Gu, J. Wang, Y. Zhang, W. Li, Y. Xu, H. Shan, W.-H. Wang, and B. Yang
Adenosine stimulates the basolateral 50 pS K channels in the thick ascending limb of the rat kidney
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F299 - F305.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Sun, D.-H. Lin, T. Wang, E. Babilonia, Z. Wang, Y. Jin, R. Kemp, A. Nasjletti, and W.-H. Wang
Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1192 - F1200.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff
Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.